Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 69 | Showing Results 1 - 5 of 344

A Randomized, Double-Blind, Placebo-Controlled Pilot of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma)

This randomized pilot clinical trial studies the side effects and best dose of naloxegol and to see how well it works in treating patients with...

Alison Conlin, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial

To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC. Stereotactic Ablative Radiotherapy has been shown in single...

Brian Louie, M.D.
  • Swedish Medical Center

SJH 14-096-Alliance A151216- A Genetic Testing for patients with Resectable or resected lung cancer. Adjuvant Lung Cancer enrichment maker identification and sequencing trial (ALCHEMIST )

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by...

Isaac Tafur, M.D.
  • Covenant Medical Center
  • SJH Texas

A Phase II Single-arm Study of Atezolizumab Monotherapy in Locally Advanced or Metastatic Non-small Cell Lung Cancer: Clinical Evaluation of Novel Blood-based Diagnostics

This is a Phase II, open-label, prospective, multicenter study designed to evaluate the efficacy and safety of single-agent atezolizumab in...

Xingwei Sui, M.D., Ph.D.
  • Providence Regional Cancer System - Aberdeen
  • Providence Regional Cancer System - Lacey

Phase 1b/II Trial of Carfilzomib with Irinotecan in Irinotecan-Sensitive Malignancies (Phase Ib) and Small Cell Lung Cancer Patients (Phase II) Who Have Progressed on Prior Platinum-based Chemotherapy (Onyx IST Reference Number: CAR-IST-553)

The purpose of this study is to determine a well-tolerated dose of Carfilzomib in combination with Irinotecan in subjects with relapsed small and...

Rachel Sanborn, M.D.
  • Oncology and Hematology Care Eastside
  • Oncology and Hematology Care Westside
« Previous 12345 Next »
Viewing Page 1 of 69 | Showing Results 1 - 5 of 344